Compare Stock Earnings
Side-by-side earnings, revenue, and financial performance comparison
Takeda Pharmaceutical Company
$18.60
+1.86%
Mkt Cap: $56.7B
Avg ER Move: ±0.7%
Next Earnings
Oct 29, 2026
In 43 days
Revenue Whisper
$1.19T
Earnings Track Record (6Q)
2 Beats
4 Misses
Whisper Beat: 33%
Last 4 Quarters
Q3'26
$0.48
✅ BEAT +17.1%
📉 -0.9%
$1.22T
Q2'26
$-0.74
❌ MISS -454%
📉 -0.1%
$1.11T
Q1'26
$0.21
✅ BEAT +0%
📈 +0.4%
$1.21T
Q4'25
$-0.03
❌ MISS -116.8%
📈 +1.6%
$1.11T
Latest Revenue
$1.22T
+10.2% YoY
Gross: 66.7%
Op: 16.5%
Net: 9.3%
Lilly(Eli) & Company
$1,137.76
+1.98%
Mkt Cap: $994.9B
Avg ER Move: ±3.3%
Next Earnings
Oct 29, 2026 BMO
In 43 days
Consensus EPS
$9.56
Whisper EPS
$10.57
Revenue Whisper
$22.70B
Earnings Track Record (7Q)
6 Beats
1 Misses
Whisper Beat: 86%
Last 4 Quarters
Q3'26
$8.38
✅ BEAT +39.4%
📈 +1.9%
$22.97B
Q2'26
$8.55
✅ BEAT +25.9%
📈 +3.1%
$19.80B
Q1'26
$7.54
✅ BEAT +5.2%
📈 +2.3%
$19.29B
Q1'26
$7.54
✅ BEAT +5.2%
📉 -7.8%
$19.29B
Latest Revenue
$22.97B
+47.7% YoY
Gross: 85.8%
Op: 39.1%
Net: 30.9%
Johnson & Johnson
$266.38
+0.30%
Mkt Cap: $607.2B
Avg ER Move: ±0.6%
Next Earnings
Oct 13, 2026 BMO
In 27 days
Consensus EPS
$3.05
Whisper EPS
$3.11
Revenue Whisper
$25.04B
Earnings Track Record (7Q)
6 Beats
0 Misses
Whisper Beat: 14%
Last 4 Quarters
Q3'26
$2.90
✅ BEAT +2.1%
📈 +1.2%
$25.31B
Q2'26
$2.70
✅ BEAT +0.7%
📉 -0.6%
$24.06B
Q1'26
$2.46
➖ MET +0%
📈 +0.2%
$24.56B
Q4'25
$2.80
✅ BEAT +1.4%
📈 +0.2%
$23.99B
Latest Revenue
$25.31B
+6.6% YoY
Gross: 73.1%
Op: 28.3%
Net: 21.9%
📊 Head-to-Head Comparison
| Metric | TAK | LLY | JNJ |
|---|---|---|---|
| Price | $18.60 | $1,137.76 | $266.38 |
| Market Cap | $56.7B | $994.9B | $607.2B |
| EPS Beat Rate | 33% | 86% | 86% |
| Whisper Beat Rate | 33% | 86% | 14% |
| Avg ER Move | ±0.7% | ±3.3% | ±0.6% |
| Next EPS Consensus | -- | $9.56 | $3.05 |
| Next EPS Whisper | -- | $10.57 | $3.11 |
| Revenue Whisper | $1.19T | $22.70B | $25.04B |
| Latest Revenue | $1.22T | $22.97B | $25.31B |
| Revenue Growth YoY | +10.2% | +47.7% | +6.6% |
| Gross Margin | 66.7% | 85.8% | 73.1% |
| Operating Margin | 16.5% | 39.1% | 28.3% |
| Net Margin | 9.3% | 30.9% | 21.9% |
| Earnings Date | Oct 29, 2026 | Oct 29, 2026 | Oct 13, 2026 |
📈 Visual Comparison
EPS Surprise % (Last 8 Quarters)
Revenue Trend
Post-Earnings Price Move
Margin Comparison
⚡ Quick Stats
TAK
33% beat rate
· ±0.7% avg move
LLY
86% beat rate
· ±3.3% avg move
JNJ
86% beat rate
· ±0.6% avg move